Skip to main content

Advertisement

Log in

Medical Management of Hypercalcemia

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. RA Fisken DA Heath AM Bold (1980) ArticleTitleHypercalcemia-a hospital survey. Quart J Med 49 405–418 Occurrence Handle1:STN:280:Bi6B2szoslU%3D Occurrence Handle7022540

    CAS  PubMed  Google Scholar 

  2. JP Bilezikian (2000) ArticleTitlePrimary hyperparathyroidism. When to observe and when to operate. Endocrinol Metab Clin North Am 29 465–478

    Google Scholar 

  3. JA Kanis RGG Russell (1977) ArticleTitleRate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its one alpha hydroxylated derivatives. Br Med J 1 78–81 Occurrence Handle1:STN:280:CSiD1cfmtFU%3D Occurrence Handle832019

    CAS  PubMed  Google Scholar 

  4. AM Parfitt (1987) ArticleTitleBone and plasma calcium homeostasis. Bone 8 S1–S8

    Google Scholar 

  5. AF Stewart RL Horst LJ Deftos EC Cadman R Lang AE Broadus (1980) ArticleTitleBiochemical evaluation of patients with cancer-associated hypercalcemia. N Engl J Med 303 1377–1383 Occurrence Handle1:STN:280:Bi6D2M3htlE%3D Occurrence Handle6253785

    CAS  PubMed  Google Scholar 

  6. SH Ralston I Fogelman MD Gardner FJ Dryburgh RA Cowan IT Boyle (1984) ArticleTitleHypercalcemia of malignancy: evidence for a non-parathyroid humoral mediator with an effect on renal tubular calcium handling. Clin Sci 66 187–191 Occurrence Handle1:STN:280:BiuC3cjkt1I%3D Occurrence Handle6692653

    CAS  PubMed  Google Scholar 

  7. SH Ralston I Fogelman MD Gardner IT Boyle (1984) ArticleTitleRelative contribution of humoral and metastatic factors to the pathogenesis of hypercalcemia in malignancy. Br Med J 288 812–813

    Google Scholar 

  8. C Isales ML Carcangui AF Stewart (1987) ArticleTitleHypercalcemia in breast cancer: a re-evaluation. Am J Med 82 1143–1147 Occurrence Handle1:STN:280:BiiB28jms1M%3D Occurrence Handle3037897

    CAS  PubMed  Google Scholar 

  9. TJ Martin LJ Suva (1989) ArticleTitleParathyroid hormone-related protein in hypercalcemia of malignancy. Clin Endocrinol 31 631–647 Occurrence Handle1:CAS:528:DyaK3cXhvFCgtA%3D%3D

    CAS  Google Scholar 

  10. V Grill P Ho JJ Body N Johanson SC Kukreja JM Moseley TJ Martin (1991) ArticleTitleParathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73 1309–1315

    Google Scholar 

  11. WJ Burtis TJ Brady JJ Orloff JB Ersbak RP Warrell BR Olson TL Wu ME Mitnick AE Broadus AF Stewart (1990) ArticleTitleImmunochemical characterisation of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of malignancy. N Engl J Med 322 1106–1112 Occurrence Handle1:STN:280:By%2BB3cngtVU%3D Occurrence Handle2320080

    CAS  PubMed  Google Scholar 

  12. BE Kemp JM Moseley CP Rodda et al. (1987) ArticleTitleParathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238 1568–1570 Occurrence Handle1:CAS:528:DyaL1cXnt12lsQ%3D%3D Occurrence Handle3685995

    CAS  PubMed  Google Scholar 

  13. AJ Yates GE Gutierrez P Smolens PS Travis MS Katz TB Aufdemorte BF Boyce TK Hymer JW Poser GR Mundy (1988) ArticleTitleEffects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J Clin Invest 81 932–938 Occurrence Handle1:CAS:528:DyaL1cXhvFyqt7w%3D Occurrence Handle3343349

    CAS  PubMed  Google Scholar 

  14. R Rizzoli JC Pache L Didierjean A Burger JP Bonjour (1994) ArticleTitleA thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab 79 912–915 Occurrence Handle1:STN:280:ByuA2MfhtVA%3D Occurrence Handle8077382

    CAS  PubMed  Google Scholar 

  15. K Yoshimoto R Yamasaki H Sakai U Tezuka M Takahashi M Iizuka T Sekiya S Saito (1989) ArticleTitleEctopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68 976–981 Occurrence Handle1:STN:280:BiaB3svkslI%3D Occurrence Handle2541161

    CAS  PubMed  Google Scholar 

  16. P Skrabanek J McPartlin D Powell (1980) ArticleTitleTumor hypercalcemia and ectopic hyperparathyroidism. Medicine (Baltimore) 59 262–282 Occurrence Handle1:STN:280:Bi%2BB3s7ns1w%3D

    CAS  Google Scholar 

  17. A Shionoiri T Horiuchi T Onouchi H Tsutsumi M Ohta T Hosoi H Ito H Orimo (2000) ArticleTitleHypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma. Intern Med 39 810–813

    Google Scholar 

  18. WA Ratcliffe AC Hutchesson NJ Bundred JG Ratcliffe (1992) ArticleTitleRole of assays for parathyroid hormone-related protein in investigation of hypercalcaemia [see comments]. Lancet 339 164–167 Occurrence Handle10.1016/0140-6736(92)90220-W Occurrence Handle1:STN:280:By2C3cnptlA%3D Occurrence Handle1346019

    Article  CAS  PubMed  Google Scholar 

  19. TA Guise GR Mundy (1998) ArticleTitleCancer and bone [Review]. Endocrine Rev 19 18–54 Occurrence Handle1:STN:280:DyaK1c7lsFyrsQ%3D%3D

    CAS  Google Scholar 

  20. JH Han SJ Choi N Kurihara M Koide Y Oba GD Roodman (2001) ArticleTitleMacrophage inflammatory protein-1 alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97 3349–3353 Occurrence Handle10.1182/blood.V97.11.3349 Occurrence Handle1:CAS:528:DC%2BD3MXktFOkt7o%3D Occurrence Handle11369623

    Article  CAS  PubMed  Google Scholar 

  21. SH Ralston RA Cowan MD Gardner WD Fraser E Marshall IT Boyle (1987) ArticleTitleComparison of intestinal calcium absorption and 1,25 dihydroxyvitamin D3 levels in malignancy-associated hypercalcemia and primary hyperparathyroidism. Clin Endocrinol 26 281–291 Occurrence Handle1:STN:280:BieD3c3os1Q%3D

    CAS  Google Scholar 

  22. S Fukomoto T Matsumoto K Ikeda et al. (1988) ArticleTitleClinical evaluation of calcium metabolism in adult T-cell leukaemia/lymphoma. Arch Intern Med 148 921–925 Occurrence Handle10.1001/archinte.148.4.921 Occurrence Handle2895617

    Article  PubMed  Google Scholar 

  23. NA Breslau JL McGuire JE Zerwekh EP Frenkel CYC Pak (1984) ArticleTitleHypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 100 1–7

    Google Scholar 

  24. M Davies ME Hayes EB Mawer GA Lumb (1985) ArticleTitleAbnormal vitamin D metabolism in Hodgkin’s lymphoma. Lancet ii 1186–1188 Occurrence Handle10.1016/S0140-6736(85)92864-8

    Article  Google Scholar 

  25. M Peacock WG Robertson BEC Nordin (1969) ArticleTitleRelation between serum and urinary calcium with particular reference to parathyroid activity. Lancet i 384–386 Occurrence Handle10.1016/S0140-6736(69)91353-1

    Article  Google Scholar 

  26. RA Kaplan MR Haussler LJ Deftos H Bone CY Pak (1977) ArticleTitleThe role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59 756–760 Occurrence Handle1:CAS:528:DyaE2sXktVemt78%3D Occurrence Handle192763

    CAS  PubMed  Google Scholar 

  27. B Buchs R Rizzoli JP Bonjour (1991) ArticleTitleEvaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia. Bone 12 47–56 Occurrence Handle1:CAS:528:DyaK3MXltFWkt7k%3D Occurrence Handle2054236

    CAS  PubMed  Google Scholar 

  28. S Jansson LE Tisell G Lindstedt PA Lundberg (1991) ArticleTitleDisodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism [see comments]. Surgery 110 480–486 Occurrence Handle1:STN:280:By6A287is1Q%3D Occurrence Handle1845370

    CAS  PubMed  Google Scholar 

  29. A Falchetti AE Bale A Amorosi C Bordi P Cicchi S Bandini SJ Marx ML Brandi (1993) ArticleTitleProgression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76 139–144 Occurrence Handle1:STN:280:ByyC3s3hsFU%3D Occurrence Handle8421078

    CAS  PubMed  Google Scholar 

  30. JS Adams (1989) ArticleTitleVitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 18 765–778

    Google Scholar 

  31. HJ Zeimer TM Greenaway J Slavin DK Hards H Zhou JC Doery AN Hunter A Duffield TJ Martin V Grill (1998) ArticleTitleParathyroid-hormone-related protein in sarcoidosis. Am J Pathol 152 17–21 Occurrence Handle1:CAS:528:DyaK1cXktlygsA%3D%3D Occurrence Handle9422518

    CAS  PubMed  Google Scholar 

  32. EB Mawer JT Hann JL Berry et al. (1985) ArticleTitleVitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci 68 141–145

    Google Scholar 

  33. GR Mundy JL Shapiro JG Bandelin EM Canalis LG Raisz (1976) ArticleTitleDirect stimulation of bone resorption by thyroid hormones. J Clin Invest 58 529–534 Occurrence Handle1:CAS:528:DyaE28XlsFCht7c%3D Occurrence Handle182721

    CAS  PubMed  Google Scholar 

  34. AF Stewart M Adler CM Byers et al. (1982) ArticleTitleCalcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 306 1136–1140 Occurrence Handle1:STN:280:Bi2C2szgt1A%3D Occurrence Handle6280047

    CAS  PubMed  Google Scholar 

  35. ES Orwoll (1982) ArticleTitleThe milk-alkali syndrome—current concepts. Ann Intern Med 97 242–249

    Google Scholar 

  36. FH Menko OLM Bijvoet JLHH Fronen LM Sandler S Adami JLH O’Riordan W Blomen-Kukenen (1983) ArticleTitleFamilial benign hypercalcemia. Quart J Med 206 120–140

    Google Scholar 

  37. SJ Marx AM Spiegel EM Brown JO Koehler DG Gardner MF Brennan GD Aurbach (1978) ArticleTitleDivalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med 65 235–242 Occurrence Handle1:CAS:528:DyaE1cXlt1Oiu7Y%3D Occurrence Handle686009

    CAS  PubMed  Google Scholar 

  38. MR Pollak EM Brown YH Chou SC Hebert SJ Marx B Steinmann T Levi CE Seidman JG Seidman (1993) ArticleTitleMutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 1297–1303 Occurrence Handle1:CAS:528:DyaK2cXhtVCjsbc%3D Occurrence Handle7916660

    CAS  PubMed  Google Scholar 

  39. AM Parfitt (1979) ArticleTitleEquilibrium and disequilibrium hypercalcemia. New light on an old concept. Metab Bone Dis Rel Res 1 279–293

    Google Scholar 

  40. JE Benabe M Martinez-Maldonado (1978) ArticleTitleHypercalcemic nephropathy. Arch Intern Med 138 777–779 Occurrence Handle10.1001/archinte.138.5.777 Occurrence Handle1:CAS:528:DyaE1cXksFOnsLs%3D Occurrence Handle646542

    Article  CAS  PubMed  Google Scholar 

  41. DJ Hosking A Cowley CA Bucknall (1981) ArticleTitleRehydration in the treatment of severe hypercalcaemia. Quart J Med 50 473–481 Occurrence Handle1:STN:280:Bi2C1MfisVM%3D Occurrence Handle7342172

    CAS  PubMed  Google Scholar 

  42. SJ Iqbal M Giles S Ledger N Nanji T Howl (1988) ArticleTitleNeed for albumin adjustments of urgent total serum calcium. Lancet ii 1477–1478 Occurrence Handle10.1016/S0140-6736(88)90945-2

    Article  Google Scholar 

  43. G Merlini LA Fitzpatrick ES Siris et al. (1984) ArticleTitleA human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia. J Clin Immunol 4 185–196 Occurrence Handle1:STN:280:BiuB2c%2Fhsl0%3D Occurrence Handle6736208

    CAS  PubMed  Google Scholar 

  44. V Grill RM Murray PW Ho JD Santamaria P Pitt C Potts G Jerums TJ Martin (1992) ArticleTitleCirculating PTH and PTHrP levels before and after treatment of tumor-induced hypercalcemia with pamidronate disodium (APD). J Clin Endocrinol Metab 74 1468–1470 Occurrence Handle1:STN:280:By2B2snkvVc%3D Occurrence Handle1592895

    CAS  PubMed  Google Scholar 

  45. J Hinnie E Bell E McKillop S Gallacher (2001) ArticleTitleThe prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 68 216–218 Occurrence Handle1:CAS:528:DC%2BD3MXktFWhu7k%3D Occurrence Handle11353947

    CAS  PubMed  Google Scholar 

  46. SH Ralston BF Boyce RA Cowan MD Gardner FJ Dryburgh IT Boyle (1986) ArticleTitleHumoral hypercalcemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour. Quart J Med 277 325–335

    Google Scholar 

  47. SH Ralston SJ Gallacher U Patel J Campbell IT Boyle (1990) ArticleTitleCancer-associated hypercalcemia: morbidity and mortality. Ann Intern Med 112 499–504 Occurrence Handle1:STN:280:By%2BC1MnnsFc%3D Occurrence Handle2138442

    CAS  PubMed  Google Scholar 

  48. PJ Ling RP A’Hern JR Hardy (1995) ArticleTitleAnalysis of survival following treatment of tumour-induced hypercalcemia with intravenous pamidronate (APD). Analysis of survival following treatment of tumour-induced hypercalcemia with intravenous pamidronate (APD). Br J Cancer 72 206–209 Occurrence Handle1:STN:280:ByqA383jtV0%3D Occurrence Handle7599053

    CAS  PubMed  Google Scholar 

  49. HIJ Harinck OLM Bijvoet AST Platingh JJ Body JWF Elte HP Sleeboom J Wildiers JP Neijt (1987) ArticleTitleRole of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride. Am J Med 82 1133–1142 Occurrence Handle1:STN:280:BiiB28jms1I%3D Occurrence Handle3300303

    CAS  PubMed  Google Scholar 

  50. SR Heller DJ Hosking (1986) ArticleTitleRenal handling of calcium and sodium in metastatic and non-metastatic malignancy. Br Med J 292 583–586 Occurrence Handle1:STN:280:BimC3s3lt1Y%3D

    CAS  Google Scholar 

  51. C Hasling P Charles L Mosekilde (1986) ArticleTitleEtidronate disodium for treating hypercalcemia of malignancy: a double blind, placebo-controlled study. Eur J Clin Invest 16 433–437 Occurrence Handle1:STN:280:BiiC3crlvF0%3D Occurrence Handle3100312

    CAS  PubMed  Google Scholar 

  52. RG Russell PI Croucher MJ Rogers (1999) ArticleTitleBisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int 9 IssueIDsuppl 2 S66–S80 Occurrence Handle10525729

    PubMed  Google Scholar 

  53. SH Ralston (1992) ArticleTitleMedical management of hypercalcemia [Review]. Br J Clin Pharm 34 11–20 Occurrence Handle1:STN:280:By2A3sfgsVY%3D

    CAS  Google Scholar 

  54. SH Ralston SJ Gallacher U Patel FJ Dryburgh WD Fraser RA Cowan IT Boyle (1989) ArticleTitleComparison of three intravenous bisphosphonates in cancer-associated hypercalcemia. Lancet ii 1180–1182 Occurrence Handle10.1016/S0140-6736(89)91791-1

    Article  Google Scholar 

  55. QS Ringerberg PS Ritch (1987) ArticleTitleEfficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients. Clin Ther 9 1–7

    Google Scholar 

  56. SH Ralston (1994) ArticleTitlePathogenesis and management of cancer-associated hypercalcemia. Cancer Surveys 21 179–196 Occurrence Handle1:CAS:528:DyaK2MXosVCnu70%3D Occurrence Handle8564993

    CAS  PubMed  Google Scholar 

  57. R Gucalp P Ritch PH Wiernik et al. (1992) ArticleTitleComparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 10 134–142 Occurrence Handle1:STN:280:By2D1M3gsFA%3D Occurrence Handle1727915

    CAS  PubMed  Google Scholar 

  58. GL Plosker KL Goa (1994) ArticleTitleClodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease [Review]. Drugs 47 945–982 Occurrence Handle1:STN:280:ByuA28vitlI%3D Occurrence Handle7521833

    CAS  PubMed  Google Scholar 

  59. OP Purohit CR Radstone C Anthony JA Kanis RE Coleman (1995) ArticleTitleA randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcemia of malignancy. Br J Cancer 72 1289–1293 Occurrence Handle1:CAS:528:DyaK28XktV2jsg%3D%3D Occurrence Handle7577484

    CAS  PubMed  Google Scholar 

  60. NP O’Rourke EV McCloskey S Vasikaran K Eyres D Fern JA Kanis (1993) ArticleTitleEffective treatment of maligant hypercalcemia with a single intravenous infusion of clodronate. Br J Cancer 67 560–563 Occurrence Handle1:STN:280:ByyC2snmvFw%3D Occurrence Handle8439504

    CAS  PubMed  Google Scholar 

  61. J Rastad L Benson H Johansson M Knuutila B Pettersson C Wallfelt G Akerstrom S Ljunghall (1987) ArticleTitleClodronate treatment in patients with malignancy-associated hypercalcemia. Acta Med Scand 221 489–494 Occurrence Handle1:STN:280:BiiB28nosVQ%3D Occurrence Handle2955674

    CAS  PubMed  Google Scholar 

  62. S Adami GP Bolzicco A Rizzo G Salvagno F Bertoldo M Rossini R Suppi V Lo Cascio (1987) ArticleTitleThe use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy. Bone Miner 2 395–404

    Google Scholar 

  63. JJ Body A Magritte F Seraj JP Sculier A Borkowski (1989) ArticleTitleAminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions. J Bone Miner Res 4 923–928

    Google Scholar 

  64. JJ Body M Pot A Borkowski JP Sculier J Klastersky (1987) ArticleTitleDose-response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia. Am J Med 82 957–963 Occurrence Handle1:STN:280:BiiB3M%2FivFI%3D Occurrence Handle3578365

    CAS  PubMed  Google Scholar 

  65. JJ Body A Borkowski A Cleeren OLM Bijvoet (1986) ArticleTitleTreatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate. J Clin Oncol 4 1177–1183 Occurrence Handle1:STN:280:BimB1c%2FmtFA%3D Occurrence Handle3016205

    CAS  PubMed  Google Scholar 

  66. SR Nussbaum J Younger CJ VandePol RF Gagel MA Zubler R Chapman IC Henderson LE Mallette (1993) ArticleTitleSingle-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages. Am J Med 95 297–304 Occurrence Handle1:STN:280:ByyA2sjmvVI%3D Occurrence Handle8368227

    CAS  PubMed  Google Scholar 

  67. SH Ralston AA Alzaid SJ Gallacher MD Gardner RA Cowan IT Boyle (1988) ArticleTitleClinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcemia. Quart J Med 258 825–834

    Google Scholar 

  68. SH Ralston MD Gardner FJ Dryburgh AS Jenkins RA Cowan IT Boyle (1985) ArticleTitleComparison of aminohydroxypropylidene diphosphonate, mithramycin and corticosteroids/calcitonin in treatment of cancer-associated hypercalcemia. Lancet ii 907–910 Occurrence Handle10.1016/S0140-6736(85)90848-7

    Article  Google Scholar 

  69. HP Sleeboom OLM Bijvoet AT Van Oosterom JH Gleed JLH O’Riordan (1983) ArticleTitleComparison of intravenous (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate and volume repletion in tumour-induced hypercalcemia. Lancet ii 239–243 Occurrence Handle10.1016/S0140-6736(83)90231-3

    Article  Google Scholar 

  70. J Walls WA Ratcliffe A Howell NJ Bundred (1994) ArticleTitleResponse to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein. Br J Cancer 70 169–172 Occurrence Handle1:STN:280:ByuB1cbis1E%3D Occurrence Handle8018531

    CAS  PubMed  Google Scholar 

  71. B Thurlimann R Waldburger HJ Senn D Thiebaud (1992) ArticleTitlePlicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial [see comments]. Ann Oncol 3 619–623 Occurrence Handle1:STN:280:ByyD1c7jt1E%3D Occurrence Handle1450043

    CAS  PubMed  Google Scholar 

  72. C Wuster KH Schoter D Thiebaud C Manegold D Krahl MR Clemens M Ghielmini P Jaeger SH Scharla (1993) ArticleTitleMethylpentylaminopropylidene bisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia. Bone Miner 22 77–85

    Google Scholar 

  73. SH Ralston D Thiebaud Z Herrmann et al. (1997) ArticleTitleDose-response study of ibandronate in the treatment of cancer-associated hypercalcemia. Br J Cancer 75 295–300 Occurrence Handle1:CAS:528:DyaK2sXhtFGksLk%3D Occurrence Handle9010041

    CAS  PubMed  Google Scholar 

  74. R Rizzoli D Thiebaud N Bundred et al. (1999) ArticleTitleSerum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab 84 3545–3550 Occurrence Handle1:CAS:528:DyaK1MXms1Oht7s%3D Occurrence Handle10522993

    CAS  PubMed  Google Scholar 

  75. JJ Body A Lortholary G Romieu AM Vigneron J Ford (1999) ArticleTitleA dose-finding study of zoledronate in hypercalcemic cancer patients. J Bone Miner Res 14 1557–1561

    Google Scholar 

  76. P Major A Lortholary J Hon E Abdi G Mills HD Menssen F Yunus R Bell J Body E Quebe-Fehling J Seaman (2001) ArticleTitleZoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 19 558–567 Occurrence Handle1:CAS:528:DC%2BD3MXhtVektLk%3D Occurrence Handle11208851

    CAS  PubMed  Google Scholar 

  77. SH Ralston AA Alzaid MD Gardner IT Boyle (1986) ArticleTitleTreatment of cancer-associated hypercalcemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J 292 1549–1550 Occurrence Handle1:STN:280:BimB2cvgvVU%3D

    CAS  Google Scholar 

  78. D Thiebaud AF Jaquet P Burckhardt (1990) ArticleTitleFast and effective treatment of malignant hypercalcemia: combination of suppositories of calcitonin and a single infusion of 3-amino-1-hydroxypropylidene-1-bisphosphonate. Arch Intern Med 150 2125–2128 Occurrence Handle10.1001/archinte.150.10.2125 Occurrence Handle1:STN:280:By6D38vktlA%3D Occurrence Handle2222097

    Article  CAS  PubMed  Google Scholar 

  79. CP Perlia NJH Gubisch J Wolter D Edelberg DD Dederick SG Taylor (1970) ArticleTitleMithramycin treatment of hypercalcemia. Cancer 25 389–394 Occurrence Handle1:STN:280:CS%2BC3cnotlI%3D Occurrence Handle5413510

    CAS  PubMed  Google Scholar 

  80. GR Mundy R Wilkinson DA Heath (1983) ArticleTitleComparative study of the available medical therapy for hypercalcemia of malignancy. Am J Med 74 421–432 Occurrence Handle1:STN:280:BiyC2cbptFA%3D Occurrence Handle6219578

    CAS  PubMed  Google Scholar 

  81. DH Fulmer AB Dimich EO Rothschild WPL Myers (1972) ArticleTitleTreatment of hypercalcemia: comparison of intravenously administered phosphate, sulphate and hydrocortisone. Arch Intern Med 129 923–930 Occurrence Handle10.1001/archinte.129.6.923 Occurrence Handle1:STN:280:CS2B3crnvVU%3D Occurrence Handle5033287

    Article  CAS  PubMed  Google Scholar 

  82. RI Breuer J Le Bauer (1967) ArticleTitleCaution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab 27 695–698 Occurrence Handle1:CAS:528:DyaF2sXkt1Snu7k%3D Occurrence Handle6025473

    CAS  PubMed  Google Scholar 

  83. LJ Deftos R Neer (1974) ArticleTitleMedical management of the hypercalcemia of malignancy. Annu Rev Med 25 323–331 Occurrence Handle10.1146/annurev.me.25.020174.001543 Occurrence Handle1:CAS:528:DyaE2cXltFChtbk%3D Occurrence Handle4277568

    Article  CAS  PubMed  Google Scholar 

  84. RP Warrell Jr WK Murphy P Schulman PJ O’Dwyer G Heller (1991) ArticleTitleA randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia. J Clin Oncol 9 1467–1475 Occurrence Handle1:STN:280:By6A3czitVU%3D Occurrence Handle1906532

    CAS  PubMed  Google Scholar 

  85. PJ Miach JK Dawborn TJ Martin et al. (1975) ArticleTitleManagement of the hypercalcemia of malignancy by peritoneal dialyssi. Med J Aust 1 782–784 Occurrence Handle1:STN:280:CSqB3MrpsFI%3D Occurrence Handle1152762

    CAS  PubMed  Google Scholar 

  86. PL Selby M Davies JS Marks EB Mawer (1995) ArticleTitleVitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol 43 531–536 Occurrence Handle1:CAS:528:DyaK28Xps1Wn

    CAS  Google Scholar 

  87. CJ Williams RA Smith RJ Ball H Wilkinson (1997) ArticleTitleHypercalcaemia in osteogenesis imperfecta treated with pamidronate [see comments]. Arch Dis Child 76 169–170 Occurrence Handle1:STN:280:ByiB387is1w%3D Occurrence Handle9068314

    CAS  PubMed  Google Scholar 

  88. AJP Yates TH Jones KI Mundy RV Hague CB Brown D Guilland-Cumming JA Kanis (1984) ArticleTitleImmobilisation hypercalcemia in adults and treatment with clodronate. Br Med J 289 1111–1112 Occurrence Handle1:STN:280:BiqD38vhtlA%3D

    CAS  Google Scholar 

  89. SJ Gallacher SH Ralston FJ Dryburgh FC Logue BF Allam BF Boyce IT Boyle (1990) ArticleTitleImmobilisation-related hypercalcemia—a possible novel mechanism and response to pamidronate. Postgrad Med J 66 918–922 Occurrence Handle1:STN:280:By6D1MrivF0%3D Occurrence Handle2267202

    CAS  PubMed  Google Scholar 

  90. HD McIntyre DP Cameron SM Urquhart WE Davies (1989) ArticleTitleImmobilization hypercalcemia responding to intravenous pamidronate therapy. Postgrad Med J 65 244–246 Occurrence Handle1:STN:280:By%2BD1c3ptVc%3D Occurrence Handle2594602

    CAS  PubMed  Google Scholar 

  91. D Kedlaya ME Brandstater JK Lee (1998) ArticleTitleImmobilization hypercalcemia in incomplete paraplegia: successful treatment with pamidronate. Arch Phys Med Rehab 79 222–225 Occurrence Handle1:STN:280:DyaK1c7jsVarsQ%3D%3D

    CAS  Google Scholar 

  92. CJ Gibbs M Peacock (1986) ArticleTitleHypercalcemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J 62 937–938 Occurrence Handle1:STN:280:BiiD2c7itlU%3D Occurrence Handle3774726

    CAS  PubMed  Google Scholar 

  93. JS Adams (1999) Hypercalcemia due to granuloma forming disorders. MJ Favus (Eds) Primer on the metabolic bone diseases and disorders of mineral metabolism. Kluwer Philadelphia 212–214

    Google Scholar 

  94. JS Adams MM Diz OP Sharma (1989) ArticleTitleEffective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111 437–438

    Google Scholar 

  95. JS Adams OP Sharma MM Diz DB Endres (1990) ArticleTitleKetoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab 70 1090–1095 Occurrence Handle1:STN:280:By%2BB3czhtlM%3D Occurrence Handle2318934

    CAS  PubMed  Google Scholar 

  96. SJ Silverberg E Shane TP Jacobs E Siris JP Bilezikian (1999) ArticleTitleA 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341 1249–1255 Occurrence Handle10.1056/NEJM199910213411701 Occurrence Handle1:STN:280:DyaK1Mvkt1alug%3D%3D Occurrence Handle10528034

    Article  CAS  PubMed  Google Scholar 

  97. CA Reasner MD Stone DJ Hosking A Ballah GR Mundy (1993) ArticleTitleAcute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate. J Clin Endocrinol Metab 77 1067–1071 Occurrence Handle1:CAS:528:DyaK2cXjvFA%3D Occurrence Handle8408454

    CAS  PubMed  Google Scholar 

  98. RA Evans (1987) ArticleTitleAminohydroxypropylidene diphosphonate treatment of hypercalcemic crisis due to primary hyperparathyroidism. Aust NZ J Med 17 58–59 Occurrence Handle1:STN:280:BiiB1MfhslA%3D

    CAS  Google Scholar 

  99. NAT Hamdy RES Gray E McCloskey J Galloway JM Rattenbury CB Brown JA Kanis (1987) ArticleTitleClodronate in the medical management of hyperparathyroidism. Bone 8 IssueIDsuppl 1 s69–s77 Occurrence Handle2961358

    PubMed  Google Scholar 

  100. E Shane DC Baquiran JP Bilezikian (1981) ArticleTitleEffects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism. Ann Intern Med 95 23–27

    Google Scholar 

  101. FJM van Breukelen OLM Bijvoet WB Frijlink HP Sleeboom H Mulder AT Van Oosterom (1982) ArticleTitleEfficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium. Calcif Tissue Int 34 321–327 Occurrence Handle1:STN:280:BiyD2M%2Fis1Q%3D Occurrence Handle6814719

    CAS  PubMed  Google Scholar 

  102. SJ Silverberg JP Bilezikian HG Bone GB Talpos MJ Horwitz AF Stewart (1999) ArticleTitleTherapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 84 2275–2285 Occurrence Handle1:CAS:528:DyaK1MXks1agt7s%3D Occurrence Handle10404790

    CAS  PubMed  Google Scholar 

  103. AF Stewart (1999) Miscellaneous causes of hypercalcemia. MJ Favus (Eds) Primer on the metabolic bone diseases and disorders of mineral metabolism. Kluwer Philadelphia 215–219

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. H. Ralston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ralston, S., Coleman, R., Fraser, W. et al. Medical Management of Hypercalcemia . Calcif Tissue Int 74, 1–11 (2004). https://doi.org/10.1007/s00223-001-1135-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-001-1135-6

Keywords

Navigation